Article

Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from…

Stem Cells International · 2017 · Graciela Ruíz, author Heriberto A. Valencia-González, author Ismael León-Galicia, author Enrique García-Villa, author Alejandro García-Carrancá, author Patricio Gariglio, author Tao-Sheng Li, Academic Editor

Key facts

Title Inhibition of RAD51 by siRNA and Resveratrol Sensitizes Cancer Stem Cells Derived from HeLa Cell Cultures to Apoptosis
First author Graciela Ruíz, author Heriberto A. Valencia-González, author Ismael León-Galicia, author Enrique García-Villa, author Alejandro García-Carrancá, author Patricio Gariglio, author Tao-Sheng Li, Academic Editor
Journal Stem Cells International
Published Apr 8, 2017
DOI 10.1155/2018/2493869
Devices mentioned BK110039, K103302
Product codes mentioned KIP, KIT, NDS, NJT, OOI, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature